Cited by 204Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

Open access

Hart, Robert G., Pearce, Lesly A., Asinger, Richard W., Herzog, Charles A.·2011·Clinical Journal of the American Society of Nephrology

DOI 10.2215/cjn.02400311PMC PMC3359566

Open this paper in CoChat — free account

Abstract

BACKGROUND AND OBJECTIVES: The efficacy of adjusted-dose warfarin for prevention of stroke in atrial fibrillation patients with stage 3 chronic kidney disease (CKD) is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with stage 3 CKD participating in the Stroke Prevention in Atrial Fibrillation 3 trials were assessed to determine the effect of warfarin anticoagulation on stroke and major hemorrhage, and whether CKD status independently contributed to stroke risk. High-risk participants (n = 1044) in the randomized trial were assigned to adjusted-dose warfarin (target international normalized ratio 2 to 3) versus aspirin (325 mg) plus fixed, low-dose warfarin (subsequently shown to be equivalent to aspirin alone). Low-risk participants (n = 892) all received 325 mg aspirin daily. The primary outcome was ischemic stroke (96%) or systemic embolism (4%). RESULTS: Among the 1936 participants in the two trials, 42% (n = 805) had stage 3 CKD at entry. Considering the 1314 patients not assigned to adjusted-dose warfarin, the primary event rate was double among those with stage 3 CKD (hazard ratio 2.0, 95% CI 1.2, 3.3) versus those with a higher estimated GFR (eGFR). Among the 516 participants with stage 3 CKD included in the randomized trial, ischemic stroke/systemic embolism was reduced 76% (95% CI 42, 90; P < 0.001) by adjusted-dose warfarin compared with aspirin/low-dose warfarin; there was no difference in major hemorrhage (5 patients versus 6 patients, respectively). CONCLUSIONS: Among atrial fibrillation patients participating in the Stroke Prevention in Atrial Fibrillation III trials, stage 3 CKD was associated with higher rates of ischemic stroke/systemic embolism. Adjusted-dose warfarin markedly reduced ischemic stroke/systemic embolism in high-risk atrial fibrillation patients with stage 3 CKD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2215/cjn.02400311

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Self-citation
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Self-citation
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
(2006) · The Lancet · doi:10.1016/s0140-6736(06)68845-4 · Cited by 1,952

Show all 28 references

Sorted by citations

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,145
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.021 · Cited by 581
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
Skanes, A. C., Healey, J. S., Cairns, J. A., Dorian, P., Gillis, A. M., McMurtry, M. S., Mitchell, L. B., Verma, A., & Nattel, S. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.01.021 · Cited by 493
2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Verma, A., Cairns, J. A., Mitchell, L. B., Macle, L., Stiell, I. G., Gladstone, D. J., McMurtry, M. S., Connolly, S. J., Cox, J. L., Dorian, P., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.001 · Cited by 478
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Turakhia, M. P., Blankestijn, P. J., Carrero, J. J., Clase, C. M., Deo, R., Herzog, C. A., Kasner, S. E., PASSMAN, R. S., Pecoits‐Filho, R., Reinecke, H., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy060 · Cited by 297
Self-citation
Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
Bonde, A. N., Lip, G. Y. H., Kamper, A., Hansen, P. R., Lamberts, M., Hommel, K., Hansen, M. L., Gislason, G., Torp-Pedersen, C. T., & Olesen, J. B. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.051 · Cited by 285
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
Chiang, C., Okumura, K., Zhang, S., Chao, T., Siu, C., Lim, T. W., Saxena, A., Takahashi, Y., & Teo, W. S. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.05.004 · Cited by 200
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation
Kumar, S., Lim, E., Covic, A. C., Verhamme, P. B., Gale, C. P., Camm, A. J., & Goldsmith, D. J. A. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.1031 · Cited by 182
Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation
Carrero, J. J., Evans, M., Szummer, K. E., Spaak, J., Lindhagen, L., Edfors, R., Stenvinkel, P., Jacobson, S. H., & Jernberg, T. (2014) · JAMA · doi:10.1001/jama.2014.1334 · Cited by 159
2018 Korean Guideline of Atrial Fibrillation Management
Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 157
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.057 · Cited by 145
Cardiovascular disease in chronic kidney disease
Marx-Schütt, K., Cherney, D. Z. I., Jankowski, J., Matsushita, K., Nardone, M., & Marx, N. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf167 · Cited by 158
Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation [RETIRED]
Culebras, A., Messe, S. R., Chaturvedi, S., Kase, C. S., & Gronseth, G. (2014) · Neurology · doi:10.1212/wnl.0000000000000145 · Cited by 133
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Potpara, T., Ferro, C. J., & Lip, G. Y. H. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.19 · Cited by 130
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán, V., Marín, F. R., Manzano‐Fernández, S., Fernández, H., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0054 · Cited by 111
Impact of Chronic Kidney Disease on Risk of Incident Atrial Fibrillation and Subsequent Survival in Medicare Patients
Nelson, S. E., Shroff, G. R., Li, S., & Herzog, C. A. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002097 · Cited by 108
Self-citation
Management of cardiovascular disease in patients with kidney disease
Kahn, M. R., Robbins, M. J., Kim, M. C., & Fuster, V. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.15 · Cited by 106
Mechanisms of Stroke in Patients with Chronic Kidney Disease
Ghoshal, S., & Freedman, B. I. (2019) · American Journal of Nephrology · doi:10.1159/000502446 · Cited by 106
Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
Eikelboom, J. W., Connolly, S. J., Gao, P., Paolasso, E., Caterina, R. D., Husted, S., O'Donnell, M. J., Yusuf, S., & Hart, R. G. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.05.007 · Cited by 107
Self-citation
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression
Mearns, E. S., White, C. M., Kohn, C. G., Hawthorne, J., Song, J.-S., Meng, J., Schein, J. R., Raut, M. K., & Coleman, C. I. (2014) · Thrombosis Journal · doi:10.1186/1477-9560-12-14 · Cited by 106
Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin: A Systematic Review and Meta-analysis
Albertsen, I. E., Rasmussen, L. H., Overvad, T. F., Graungaard, T., Larsen, T. B., & Lip, G. Y. H. (2013) · Stroke · doi:10.1161/strokeaha.113.000883 · Cited by 101
Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages
Dad, T., & Weiner, D. E. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.06.003 · Cited by 102
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis
Nielsen, P. B., Lane, D. A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0797-9 · Cited by 97
Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease
Hart, R. G., Eikelboom, J. W., Brimble, K. S., McMurtry, M. S., & Ingram, A. J. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.04.005 · Cited by 89
Self-citation
Incident Atrial Fibrillation and Risk of Death in Adults With Chronic Kidney Disease
Bansal, N., Fan, D., Hsu, C., Ordoñez, J. D., & Go, A. S. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001303 · Cited by 89
A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-2103 · Cited by 87
The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy
Schuett, K. A., Marx, N., & Lehrke, M. (2023) · Circulation Research · doi:10.1161/circresaha.122.321748 · Cited by 89
Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation
Ng, K. P., Edwards, N. C., Lip, G. Y. H., Townend, J., & Ferro, C. J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.381 · Cited by 82
Anticoagulants in atrial fibrillation patients with chronic kidney disease
Hart, R. G., Eikelboom, J. W., Ingram, A. J., & Herzog, C. A. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.160 · Cited by 75
Self-citation
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis
Andò, G., & Capranzano, P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.303 · Cited by 79
Meta-Analysis of the Influence of Chronic Kidney Disease on the Risk of Thromboembolism Among Patients With Nonvalvular Atrial Fibrillation
Providencia, R. A., Marijon, É., Bovéda, S., Barra, S., Narayanan, K., Heuzey, J. L., Gersh, B. J., & Gonçalves, L. M. M. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.048 · Cited by 67
Chronic Kidney Disease and Stroke
Husseini, N. E., Kaskar, O. B., & Goldstein, L. B. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.09.001 · Cited by 57
Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis
Chan, P., Huang, D., Yip, P.-S., Hai, J. J., Tse, H., Chan, T. M., Lip, G. Y. H., Lo, W.-K., & Siu, C. (2015) · EP Europace · doi:10.1093/europace/euv289 · Cited by 55
Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
Potpara, T., & Lip, G. Y. H. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.003 · Cited by 52
Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
Ng, K. H., Hart, R. G., & Eikelboom, J. W. (2013) · Cardiology and Therapy · doi:10.1007/s40119-013-0019-y · Cited by 49
Self-citation
Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients
Krüger, T., Brandenburg, V. M., Schlieper, G., Marx, N., & Floege, J. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs485 · Cited by 46
Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease
Reinecke, H., Näbauer, M., Gerth, A., Limbourg, T., Treszl, A., Engelbertz, C. M., Eckardt, L., Kirchhof, P. F., Wegscheider, K., Ravens, U., et al. (2014) · Kidney International · doi:10.1038/ki.2014.195 · Cited by 47
Preventing Stroke in Patients With Chronic Kidney Disease and Atrial Fibrillation
Reinecke, H., Engelbertz, C. M., & Schäbitz, W. (2013) · Stroke · doi:10.1161/strokeaha.113.001701 · Cited by 44
Renal Function Considerations for Stroke Prevention in Atrial Fibrillation
Fanikos, J. R., Burnett, A., Mahan, C. E., & Dobesh, P. P. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.04.015 · Cited by 43
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.013 · Cited by 44
Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation
Jun, M., James, M. T., Ma, Z., Zhang, J., Tonelli, M. A., McAlister, F. A., Manns, B., Ravani, P., Quinn, R. R., Wiebe, N., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.018 · Cited by 42
Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
Arnson, Y., Hoshen, M., Senderey, A. B., Reges, O., Balicer, R. D., Leibowitz, M., Tsadok, M. A., & Haim, M. (2020) · Cardiology · doi:10.1159/000504877 · Cited by 43
Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease
Kooiman, J., van Rein, N., Spaans, B., van Beers, K. A. J., Bank, J. R., van de Peppel, W. R., del Sol, A. I., Cannegieter, S. C., Rabelink, T. J., Lip, G. Y. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094420 · Cited by 38
Management of atrial fibrillation in chronic kidney disease: Double trouble
Nimmo, C., Wright, M. J., & Goldsmith, D. J. A. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.010 · Cited by 35
Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis
Shen, C., Zheng, C., Kiu, K., Chen, H.-A., Wu, C., Lu, K., Hsu, Y., Lin, Y., & Wang, Y. (2016) · Medicine · doi:10.1097/md.0000000000003933 · Cited by 37
Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation
Heine, G. H., Brandenburg, V. M., & Schirmer, S. H. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0287 · Cited by 37
Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation
Stamellou, E., & Floege, J. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx322 · Cited by 36
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study
Russo, V., Attena, E., Maio, M. D., Mazzone, C., Carbone, A., Parisi, V., Rago, A., D’Onofrio, A., Golino, P., & Nigro, G. (2019) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-019-01923-9 · Cited by 36
The atrial fibrillation conundrum in dialysis patients
Vriese, A. S. D., Caluwé, R., & Raggi, P. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.01.010 · Cited by 32
Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview.
Kulkarni, N. N., Gukathasan, N., Sartori, S., & Baber, U. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.448 · Cited by 32
Global forecasting of chronic kidney disease mortality rates and numbers with the generalized additive model
Shahbazi, F., Doosti‐Irani, A., Soltanian, A. R., & Poorolajal, J. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03720-w · Cited by 33
Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis
Wong, C. X. J., Odutayo, A., Emdin, C. A., Kinnear, N. J., & Sun, M. T. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.03.042 · Cited by 31
Intersection of cardiovascular disease and kidney disease
Bansal, N., Hsu, C., & Go, A. S. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000444820.80249.56 · Cited by 30
Atrial fibrillation and chronic kidney disease: A review of options for therapeutic anticoagulation to reduce thromboembolism risk
Bhatia, H. S., Hsu, J. C., & Kim, R. J. (2018) · Clinical Cardiology · doi:10.1002/clc.23085 · Cited by 30
Comparison of novel oral anticoagulants versus vitamin K antagonists in patients with chronic kidney disease
Harel, Z., Sood, M. M., & Perl, J. M. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000098 · Cited by 27
Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
Ding, W. Y., Potpara, T., Blomström‐Lundqvist, C., Boriani, G., Marín, F. R., Fauchier, L., Lip, G. Y. H., & the ESC‐EHRA EORP‐AF Long‐Term General Registry Investigators (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13745 · Cited by 26
Vitamin K Antagonists: Beyond Bleeding
Krüger, T., & Floege, J. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12175 · Cited by 27
Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update
Burlacu, A., Genovesi, S., Ortíz, A., Combe, C., Basile, C., Schneditz, D., SANDE, F. M. V. D., Popa, G. T., Moroșanu, C., & Covic, A. C. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz040 · Cited by 28
Incidence of severe renal dysfunction among individuals taking warfarin and implications for non–vitamin K oral anticoagulants
Fanola, C. L., Mooney, D., Cowan, A. J., Ko, D., Sisson, E., Henault, L. E., Tripodis, Y., & Hylek, E. M. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.08.017 · Cited by 26
Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation
Airy, M., Schold, J. D., Jolly, S. E., Arrigain, S., Bansal, N., Winkelmayer, W. C., Nally, J. V., & Navaneethan, S. D. (2018) · American Journal of Nephrology · doi:10.1159/000491023 · Cited by 26
Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device
Luani, B., Genz, C., Herold, J., Mitrasch, A., Mitusch, J., Wiemer, M., Schmeißer, A., Braun-Dullaeus, R. C., & Rauwolf, T. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1097-0 · Cited by 26
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
Flaker, G., Turagam, M. K., & Velagapudi, P. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s80641 · Cited by 24
Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients with renal dysfunction
Lee, K. H., Park, H. W., Cho, J. G., Yoon, N. S., Kim, S. S., Kim, J.-H., Kim, M. C., Cho, K. H., Kim, H. K., Kim, C. H., et al. (2015) · EP Europace · doi:10.1093/europace/euv198 · Cited by 24
Clinical Outcomes of Warfarin Initiation in Advanced Chronic Kidney Disease Patients With Incident Atrial Fibrillation
Agarwal, M. A., Potukuchi, P. K., Sumida, K., Naseer, A., Molnar, M. Z., George, L. K., Koshy, S. K. G., Streja, E., Thomas, F., Kalantar‐Zadeh, K., et al. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.06.036 · Cited by 24
Balancing the risks of stroke and bleeding in CKD
Qamar, A., & Bhatt, D. L. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.14 · Cited by 24
Non–Vitamin K–Dependent Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With CKD: Pragmatic Considerations for the Clinician
Shroff, G. R., Stoecker, R., & Hart, A. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.02.360 · Cited by 22
Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation
Lenihan, C. R., Montez‐Rath, M. E., Shen, J. I., Scandling, J. D., Turakhia, M. P., Chang, T. I., & Winkelmayer, W. C. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu323 · Cited by 21
Risk of bleeding with concomitant use of oral anticoagulants and aspirin: A systematic review and meta-analysis
Ghule, P., Panich, J., & Malone, D. C. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae010 · Cited by 19
Prescription of DOACs in Patients with Atrial Fibrillation at Different Stages of Renal Insufficiency
Hahn, K. M., & Lamparter, M. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02544-8 · Cited by 21
Stroke Features and Management in Patients with Chronic Kidney Disease
Kamouchi, M. (2013) · Contributions to nephrology · doi:10.1159/000346727 · Cited by 20
Impact of Renal Dysfunction on Clinical Outcome in Patients With Low Risk of Atrial Fibrillation
Lin, W., Lin, Y., Chung, F., Chao, T., Liao, J., Chang, S., Lo, L., Hu, Y., Chiang, C., Cheng, S., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1246 · Cited by 20
Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist’s perspective
Ravera, M., Bussalino, E., Fusaro, M., Lullo, L. D., Aucella, F., & Paoletti, E. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00720-5 · Cited by 21
Atrial fibrillation in chronic kidney disease
Voroneanu, L. E., Ortíz, A., Nistor, I., & Covic, A. C. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.04.007 · Cited by 20
Warfarin Treatment in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
Winkelmayer, W. C., & Turakhia, M. P. (2014) · JAMA · doi:10.1001/jama.2014.1781 · Cited by 20
Safety of antithrombotic drugs in patients with atrial fibrillation and non-end-stage chronic kidney disease: Meta-analysis and systematic review
Bai, Y., Chen, H., Yang, Y., Li, L., Liu, X., Shi, X.-B., & Ma, C. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.11.020 · Cited by 20
Novel Anticoagulants in Atrial Fibrillation: A Primer for the Primary Physician
Mookadam, M., Shamoun, F. E., & Mookadam, F. (2015) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2015.04.140297 · Cited by 19
Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease
Patel, N. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i7.397 · Cited by 19
Warfarin use increases bleeding risk in hemodialysis patients with atrial fibrillation: A meta‐analysis of cohort studies
Hussain, S., Siddiqui, A. N., Baxi, H., Habib, A., Hussain, M. S., & Najmi, A. K. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14601 · Cited by 19
Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Decade of Experience
Spruit, J. R., de Vries, T. A. C., Hemels, M. E. W., Pisters, R., de Groot, J. R., & Jansen, R. W. M. M. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01138-5 · Cited by 18
Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation
Zhang, J., Chen, K., & Zhang, S. (2015) · Medicine · doi:10.1097/md.0000000000000409 · Cited by 18
Improvement of HAS-BLED bleeding score predictive capability by changing the definition of renal dysfunction in Japanese atrial fibrillation patients on anticoagulation therapy
Suzuki, M., Matsue, Y., Nakamura, R. A., Matsumura, A., & Hashimoto, Y. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.03.006 · Cited by 18
Antikoagulation bei Patienten mit chronischer Niereninsuffizienz
Schlieper, G., Schwenger, V., Remppis, A., Keller, T., Dechend, R., Maßberg, S., Baldus, S. E., Weinreich, T., Hetzel, G. R., Floege, J., et al. (2017) · Der Internist · doi:10.1007/s00108-017-0220-5 · Cited by 19
Personalizing oral anticoagulant treatment in patients with atrial fibrillation
Capranzano, P., Miccichè, E., D’Urso, L., Privitera, F., & Tamburino, C. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.818819 · Cited by 18
Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease
Albrecht, D., Turakhia, M. P., Ries, D., Marbury, T. C., Smith, W. J. B., Dillon, D., Milner, P. G., & Midei, M. G. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-10-0815 · Cited by 18
Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.
Khouri, Y. S., Stephens, T., Ayuba, G. A., Al‐Ameri, H., Juratli, N., & McCullough, P. A. (2015) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1069 · Cited by 18
Atrial fibrillation and chronic kidney disease: focus on rivaroxaban
Barrios, V., & Górriz, J. L. (2015) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.15.44 · Cited by 17
Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease
Garlo, K. G., Steele, D., Nigwekar, S. U., & Chan, K. E. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06430518 · Cited by 16
A Pint of Sweat Will Save a Gallon of Blood
Granger, C. B., & Chertow, G. M. (2014) · Circulation · doi:10.1161/circulationaha.113.007549 · Cited by 16
Is anticoagulating haemodialysis patients with non‐valvular atrial fibrillation too risky?
Parker, K., Mitra, S., & Thachil, J. V. (2018) · British Journal of Haematology · doi:10.1111/bjh.15144 · Cited by 16
Stroke Prevention in Patients With Atrial Fibrillation and Renal Dysfunction
Kaatz, S., & Mahan, C. E. (2014) · Stroke · doi:10.1161/strokeaha.114.005117 · Cited by 14
Management of Adults with Newly Diagnosed Atrial Fibrillation with and without CKD
Bansal, N., Zelnick, L. R., Reynolds, K., Harrison, T. N., Lee, M. S., Singer, D. E., Sung, S. H., Fan, D., & Go, A. S. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021060744 · Cited by 14

Authors: Hart, R. G., Pearce, L. A., Asinger, R. W., & Herzog, C. A.
Affiliations: The University of Texas at San Antonio Health Science Center (US)
Hennepin County Medical Center (US)
Corresponding author: Hart, Robert G.
ORCID: Hart, Robert G.
Pearce, Lesly A.
Herzog, Charles A.
Venue: Clinical Journal of the American Society of Nephrology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2011-11
Volume: 6
Issue: 11
Pages: 2599-2604
ISSN: 1555-9041 (ISSN-L)
DOI: 10.2215/cjn.02400311
PMC: PMC3359566
OpenAlex: W2130977972
Cited by: 204
References: 28
Citations by year: 2026: 5 · 2025: 5 · 2024: 5 · 2023: 13 · 2022: 3 · 2021: 7 · 2020: 11 · 2019: 14 · 2018: 21 · 2017: 14 · 2016: 19 · 2015: 21 · 2014: 34 · 2013: 22 · 2012: 10
FWCI: 14.47
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Clinical Journal of the American Society of Nephrology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ns024224-11)
National Institute of Neurological Disorders and Stroke (R01NS24224)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: warfarin, atrial fibrillation, chronic kidney disease stage 3, stroke prevention, ischemic stroke, systemic embolism, major bleeding, aspirin, anticoagulation, estimated glomerular filtration rate
MeSH terms: Aged, Anticoagulants, Aspirin, Atrial Fibrillation, Blood Coagulation, Canada, Chronic Disease, Drug Therapy, Combination, Female, Hemorrhage, Humans, Kidney Diseases, Male, Platelet Aggregation Inhibitors, Risk Factors, Severity of Illness Index, Time Factors, United States, Warfarin, Chi-Square Distribution, Proportional Hazards Models, Treatment Outcome, Risk Assessment, International Normalized Ratio, Stroke, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks